Navigation Links
Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHA(TM)
Date:6/25/2008

COLUMBIA, Md., June 25 /PRNewswire-FirstCall/ -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA-omega 3 essential for infant brain and eye development, is now available to Eastern European consumers in the new Pregnium prenatal supplement from Walmark. Featuring 200 mg per serving of life'sDHA, Pregnium is available at major retailers in the Czech Republic, Slovakia and Romania.

"There is a strong body of scientific evidence supporting the importance of DHA to pregnant women and the development and health of their babies," said John Dobson, Martek's managing director of sales and marketing for Europe. "Martek is pleased to be working with Eastern European supplements leader Walmark to make a trusted source of DHA available to consumers in this part of the world."

DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews have noted the importance of DHA omega-3 in proper brain and eye development and function, and there are clinical studies underway to evaluate its role in decreasing the prevalence of certain neurological disorders.

DHA is important throughout pregnancy, particularly in the third trimester when significant brain growth occurs. Maternal DHA supplementation during pregnancy and nursing significantly enhances the level of DHA available to the fetus and infant. Studies have shown that maternal DHA supplementation may improve infant developmental outcomes, such as eye-hand coordination, motor skills and attention span. Women of childbearing age who consume a typical Western diet are at risk for low stores of DHA. This is because the primary dietary source of DHA is fatty fish, a dietary choice that is not typically a staple of the Western diet. Additionally, expert bodies have advised pregnant and nursing women to limit their consumption of certain types of fish due to the potentially high levels of toxins such as mercury.

Fish are often thought to be the only source of DHA omega-3. However, life'sDHA offers a trusted, vegetarian form of DHA that contains no oceanic pollutants and toxins. Fish are good sources of DHA because of the DHA-rich microalgae in their food chain; life'sDHA is derived from microalgae and produced in an FDA-inspected facility from start to finish using a sustainable source that does not deplete ocean resources. life'sDHA is found in numerous foods, beverages and supplements for people of all ages. It is also the only source of DHA used in U.S. infant formula and is available in more than 95 percent of the formulas on the U.S. market and in infant formula products sold in more than 75 countries around the world.

A modern pharmaceutical company specializing in the manufacture and sale of nutritional supplements and pharmaceuticals, Walmark leads the supplements market in the Czech Republic, Slovakia, Romania and Bulgaria and is one of the top three market leaders in Poland, Hungary and Lithuania. Exporting to more than 20 countries in the world, including regions in Europe and the Middle and the Far East, Walmark maintains a successful product portfolio of nutritional supplements and continues to develop products in the pharmaceutical and sports nutrition segments.

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com. For a complete list of products containing life'sDHA, visit http://www.lifesdha.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2007 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.

Cassie France-Kelly

Public Relations

Martek Biosciences

(443) 542-2116

media@martek.com

Kyle Stults

Investor Relations

Martek Biosciences

(410) 740-0081

investors@martek.com


'/>"/>
SOURCE Martek Biosciences
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania
2. LifeCell Corporation Schedules First Quarter 2008 Financial Results Conference Call; April 24, 2008 at 10:00 A.M. Eastern
3. Eastern Ergonomics Conference, June 24 in New York City; New One-Day Format, Focus on Core Ergonomics Education
4. Northeastern University and Mass General Hospital Increase the Accuracy, While Reducing the Diagnosis Time, for Breast Cancer Detection
5. LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern
6. CardioTech Announces Conference Call on February 12 at 2:30 PM Eastern for Third Quarter of Fiscal 2008
7. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
8. LifeCell Corporation Schedules Third Quarter 2007 Financial Results Conference Call; October 25, 2007 at 10:00 A.M. Eastern
9. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
10. Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association
11. Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... ... became double board-certified in surgery and surgery of the hand by the National ... no stranger to going above and beyond in his pursuit of providing the ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. ... the company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar ... FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is ...
(Date:5/23/2016)... ... ... blood donations in South Texas and across the nation is growing. , But according to ... are on the decline. In fact, donations across the country are at their lowest point ... the last four years alone. , There is no substitute for blood. , “We want ...
(Date:5/23/2016)... North Carolina (PRWEB) , ... May 23, 2016 ... ... automation and building management solutions and services based in Aurora, Ohio, has broken ... of established business in the Research Triangle Park area, this new location solidifies ...
Breaking Biology Technology:
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
(Date:3/17/2016)... -- ABI Research, the leader in transformative technology ... will reach more than $30 billion by 2021, ... electronics, particularly smartphones, continue to boost the biometrics ... two billion shipments by 2021 at a 40% ... Analyst at ABI Research. "Surveillance is also gearing ...
(Date:3/14/2016)... March 14, 2016 NXTD ) ("NXT-ID" ... commerce market, announces the airing of a new series of ... week of March 21 st .  The commercials will air ... popular Squawk on the Street show. --> NXTD ... growing mobile commerce market, announces the airing of a new ...
Breaking Biology News(10 mins):